Evidence map›Paper›PMID 40728630›Full record

ArticleDiscover nano2025

Bimetallic nanoparticles synthesized from Korean red ginseng (Panax ginseng) root extract as nanocatalysts and in vitro antibacterial activity of Au-Ag alloy.

Gayeon Lee, Youmie Park

Abstract read
In one paragraph

Article in Discover nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gayeon LeeCollege of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, 197 Inje-Ro, Gimhae, Gyeongnam, 50834, Republic of Korea.
Youmie ParkCollege of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, 197 Inje-Ro, Gimhae, Gyeongnam, 50834, Republic of Korea. youmiep@inje.ac.kr.ORCID http://orcid.org/0000-0002-0193-9613

Funding

National Research Foundation of Korea 2018R1D1A1B07041709
6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) and gold nanoparticles (AuNPs) were green-synthesized using Korean red ginseng root extract as a reducing agent, and both types of nanoparticles were used as seeds for the synthesis of bimetallic nanoparticles (BNPs). Five types of BNPs were synthesized by adding gold ions, platinum ions, and palladium ions to the seed colloidal solution. The synthesized BNPs were thoroughly characterized via UV‒visible spectrophotometry, field-emission transmission electron microscopy, scanning transmission electron microscopy, energy-dispersive spectroscopy with elemental mapping, high-resolution X-ray diffraction, and dynamic light scattering. The average sizes of the gold-silver BNPs (Au-Ag) (16.59 ± 5.14 nm), palladium-silver BNPs (Pd-Ag) (45.34 ± 15.14 nm), platinum-silver BNPs (Pt-Ag) (39.95 ± 9.59 nm), palladium-gold BNPs (Pd-Au) (11.09 ± 2.17 nm) and platinum-gold BNPs (Pt-Au) (12.14 ± 3.39 nm) were measured from FE-TEM images. Five types of BNPs had an alloy structure with a face-centered cubic crystallinity. In addition, Au-Ag, Pt-Au and Pd-Au were spherical, whereas Pt-Ag and Pd-Ag had sea urchin-like shapes. The atomic percentages of Pd-Ag and Pt-Ag demonstrated approximately the same ratio (50:50) of bimetals. Moreover, the spherical BNPs were composed of approximately 70% Au, and the remaining 30% consisted of Ag, Pd or Pt. Catalytic applications demonstrated that Pd-Au, with the smallest average size, had the highest catalytic activity for methyl orange (22.29 × 10

Indexed as

Antibacterial activityBimetallic nanoparticlesNanocatalystRed ginseng root extractVancomycin-resistant Enterococci

Identifiers

PMID40728630
PMCPMC12307836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.